股票 › GENB
生成生物医药 GENB
美股市值排名 #2859
$13.06 +$0.49 (+3.90%)
休市 · Nov 6, 8:10 pm ET · 最新盘后价 $13.06 0.00%
开盘$12.90
昨收$12.57
当日区间$12.47 – $13.17
成交量632.2K
市值$1.68B
市盈率（TTM）–
股息率–
分析师观点
一致评级买入
分析师人数3
平均目标价$26.00+99.1% 较现价
- 买入 100%
最低 $22.00现价 $13.06均值 $26.00最高 $30.00
最新评级变动
已记录的最近20次评级动作给出的目标价区间为$16.00至$30.00，平均为$26.80。
| 日期 | 机构 | 评级 | 目标价 |
|---|---|---|---|
| 30 Oct 2026 | H.C. Wainwright | BUY | $30.00 |
| 29 Oct 2026 | H.C. Wainwright | BUY | $30.00 |
| 15 Oct 2026 | H.C. Wainwright | BUY | $30.00 |
| 14 Oct 2026 | Piper Sandler | BUY | $26.00 |
| 14 Oct 2026 | H.C. Wainwright | BUY | $30.00 |
| 5 Oct 2026 | H.C. Wainwright | BUY | $30.00 |
| 2 Oct 2026 | Piper Sandler | BUY | $26.00 |
| 9 Sep 2026 | H.C. Wainwright | BUY | $30.00 |
| 8 Sep 2026 | H.C. Wainwright | BUY | $30.00 |
| 28 Aug 2026 | H.C. Wainwright | BUY | $30.00 |
| 17 Aug 2026 | Morgan Stanley | BUY | $22.00 |
| 7 Aug 2026 | Piper Sandler | BUY | $24.00 |
| 7 Aug 2026 | H.C. Wainwright | BUY | $25.00 |
| 24 Jun 2026 | Guggenheim | BUY | $30.00 |
| 15 Jun 2026 | Guggenheim | BUY | $30.00 |
| 14 May 2026 | Morgan Stanley | BUY | $22.00 |
| 8 May 2026 | Piper Sandler | BUY | $24.00 |
| 8 May 2026 | H.C. Wainwright | BUY | $25.00 |
| 13 Apr 2026 | H.C. Wainwright | BUY | $16.00 |
| 9 Apr 2026 | Goldman Sachs | BUY | $26.00 |
暂无评论——快来第一个聊聊 GENB。
登录后参与讨论。